In patients without heart failure or left ventricular dysfunction after acute myocardial infarction, β-blockers were not associated with reduced mortality up to 1 year.
Does β-blocker use reduce mortality in survivors of acute myocardial infarction without heart failure or ventricular dysfunction?
Survivors of hospitalization with acute myocardial infarction (AMI) who did not have heart failure (HF) or left ventricular systolic dysfunction (LVSD)
β-blockers
No β-blocker use
Risk of death at any time point up to 1 yearhard clinical
In survivors of acute myocardial infarction without heart failure or left ventricular systolic dysfunction, routine beta-blocker use was not associated with improved 1-year survival.
Absolute Event Rate: 0% vs 0%
Among survivors of hospitalization with AMI who did not have HF or LVSD as recorded in the hospital, the use of β-blockers was not associated with a lower risk of death at any time point up to 1 year. (β-Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart Failure; NCT02786654).
Building similarity graph...
Analyzing shared references across papers
Loading...
Dondo et al. (Wed,) reported a other. In patients without heart failure or left ventricular dysfunction after acute myocardial infarction, β-blockers were not associated with reduced mortality up to 1 year.
synapsesocial.com/papers/69697d6d8374bfe05cda3468 — DOI: https://doi.org/10.1016/j.jacc.2017.03.578
Tatendashe B Dondo
General Cardiology
Marlous Hall
General Cardiology
Robert West
Smithsonian Institution
Journal of the American College of Cardiology
University College London
University of Edinburgh
Université Paris Cité
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: